Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells
Crossref DOI link: https://doi.org/10.1186/s13046-017-0492-6
Published Online: 2017-02-06
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Shoubing
Wu, Dan
Yin, Xiaodong
Jin, Xiaoxiao
Zhang, Xiu
Zheng, Shiya
Wang, Cailian
Liu, Yanwen
Funding for this research was provided by:
the National Nature Science Foundation of People’s Republic of China (81271699)